By Scott Graham | May 16, 2019
Durie Tangri's Mark Lemley, an attorney for a would-be class of consumers and insurers, says a 2015 ruling on a Spider-Man toy established limits on royalties that drug companies are ignoring.
Delaware Business Court Insider | News
By Scott Graham | May 7, 2019
Judge Joseph Bataillon says he will enjoin L'Oreal from marketing products that infringe a patent held by Olaplex LLC—notwithstanding a Patent Trial and Appeal Board decision finding the patent invalid.
Delaware Business Court Insider | News
By Scott Graham | May 7, 2019
Though Cipla's claims of a fraud on the public and the courts is "far from proven," the parties' license agreement prevents Amgen from pretrial relief, Judge Leonard Stark ruled.
Delaware Business Court Insider | News
By Tom McParland | May 2, 2019
A Delaware federal judge on Thursday approved an agreement by San Francisco-based Genentech and Sandoz to dismiss the two entities, without prejudice, from the lawsuit, because neither had been involved in filing an abbreviated new drug application at the heart of the dispute.
Delaware Business Court Insider | News
By Tom McParland | April 5, 2019
Thursday's verdict followed seven days of trial in the case, targeting Apple's iPhone and iPad products, and dealt a blow to Evolved, which had filed similar suits against other cell phone companies over the same patents.
Delaware Business Court Insider | News
By Tom McParland | April 1, 2019
The ruling found that Travis Kalanick faced a "substantial likelihood of liability" for failing to heed warnings that Otto founder Anthony Levandowski had downloaded thousands of proprietary files from Google's self-driving business Waymo before he left to form the San Francisco-based startup.
Delaware Business Court Insider | News
By Tom McParland | March 28, 2019
U.S. Chief Judge Leonard P. Stark ruled there was no evidence Quest Licensing Corp. had acted in bad faith by pursuing its claims.
By Kirt O'Neill and Clayton Matheson | March 28, 2019
Out of concern for limiting the “extraterritorial” reach of America's patent laws, courts have long held that prevailing infringement plaintiffs…
Delaware Business Court Insider | News
By Tom McParland | March 11, 2019
In a court filing Friday, Baxalta Inc. argued that Bayer's patent was invalid and that the German-based pharmaceutical firm had presented no evidence to support the jury's damages award.
Delaware Business Court Insider | News
By Tom McParland | February 7, 2019
According to court records posted Tuesday, the Wilmington jury rejected Baxalta's arguments that Bayer's patent was invalid after six days of trial in the case, which was filed in December 2016, when Baxalta was still owned by Irish biopharmacuetical firm Shire.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
Black Owl Recruiting is looking for a number of qualified applicants to fill positions for a highly reputable client. Recent experience work...
McManimon, Scotland & Baumann, LLC is seeking talented and motivated Associate Attorneys with 3-7 years of experience working closely wi...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS